OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
VITROA55

Vitro SAB de CV

Commodity ChemicalsVerified

Vitro maintains a conservative capital structure with a debt-to-equity ratio of 0.25, significantly below the industry median for Commodity Chemicals. The company's liquidity position is characterized by a current ratio of 1.2, indicating moderate short-term solvency. Free cash flow of $132.08 million supports operational flexibility, though cash and equivalents of $24.39 million are relatively low compared to total liabilities of $635.90 million. Profitability metrics show strong performance, with a return on equity (ROE) of 19.24% and a return on assets (ROA) of 9.9%. These figures exceed the industry median for Commodity Chemicals, reflecting efficient asset utilization and strong earnings power. Operating income of $34.49 million and net income of $129.62 million highlight the company's ability to convert revenue into profit, with a gross profit margin of 36.5%. Geographically, Vitro's revenue is concentrated in Mexico, with limited exposure to international markets. The company's business is segmented into flat glass and glass containers, with flat glass accounting for the majority of revenue. This concentration increases exposure to regional economic conditions and regulatory changes in Mexico. Growth trajectory is positive, with revenue of $282.03 million in the latest period. While no specific outlook is provided for the next fiscal year, the company's strong free cash flow and low dilution risk suggest a stable growth path. Historical capital expenditures of -$22.85 million indicate a focus on cost optimization rather than expansion. Risk factors include moderate liquidity risk due to a current ratio of 1.2 and a negative net cash position after subtracting total debt. Dilution risk is low, with no significant changes in shares outstanding between basic and diluted shares. The company's risk assessment highlights the need for continued monitoring of debt levels and cash flow generation. Recent events include the latest financial filing, which provides updated financial metrics and confirms the company's strong profitability. No major regulatory or operational events have been disclosed in the latest period, suggesting a stable operating environment.

30-day price · VITROA-0.04 (-0.7%)
Low$5.34High$5.78Close$5.58As of18 May, 00:00 UTC
Profile
CompanyVitro SAB de CV
TickerVITROA.MX
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Vitro SAB de CV is a Mexican glass manufacturing company that produces and distributes flat glass, glass containers, and glass packaging products, primarily serving the construction and beverage industries.

Classification. Vitro is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

Vitro maintains a conservative capital structure with a debt-to-equity ratio of 0.25, significantly below the industry median for Commodity Chemicals. The company's liquidity position is characterized by a current ratio of 1.2, indicating moderate short-term solvency. Free cash flow of $132.08 million supports operational flexibility, though cash and equivalents of $24.39 million are relatively low compared to total liabilities of $635.90 million. Profitability metrics show strong performance, with a return on equity (ROE) of 19.24% and a return on assets (ROA) of 9.9%. These figures exceed the industry median for Commodity Chemicals, reflecting efficient asset utilization and strong earnings power. Operating income of $34.49 million and net income of $129.62 million highlight the company's ability to convert revenue into profit, with a gross profit margin of 36.5%. Geographically, Vitro's revenue is concentrated in Mexico, with limited exposure to international markets. The company's business is segmented into flat glass and glass containers, with flat glass accounting for the majority of revenue. This concentration increases exposure to regional economic conditions and regulatory changes in Mexico. Growth trajectory is positive, with revenue of $282.03 million in the latest period. While no specific outlook is provided for the next fiscal year, the company's strong free cash flow and low dilution risk suggest a stable growth path. Historical capital expenditures of -$22.85 million indicate a focus on cost optimization rather than expansion. Risk factors include moderate liquidity risk due to a current ratio of 1.2 and a negative net cash position after subtracting total debt. Dilution risk is low, with no significant changes in shares outstanding between basic and diluted shares. The company's risk assessment highlights the need for continued monitoring of debt levels and cash flow generation. Recent events include the latest financial filing, which provides updated financial metrics and confirms the company's strong profitability. No major regulatory or operational events have been disclosed in the latest period, suggesting a stable operating environment.
Key takeaways
  • Vitro maintains a strong ROE of 19.24% and ROA of 9.9%, outperforming the Commodity Chemicals industry median.
  • The company's debt-to-equity ratio of 0.25 indicates a conservative capital structure with low leverage.
  • Free cash flow of $132.08 million provides operational flexibility and supports dividend or reinvestment opportunities.
  • Revenue concentration in Mexico and the flat glass segment increases exposure to regional economic and regulatory risks.
  • Low dilution risk and stable shares outstanding suggest a disciplined capital management approach.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$282.0M
Gross profit$102.9M
Operating income$34.5M
Net income$129.6M
R&D
SG&A
D&A
SBC
Operating cash flow$135.5M
CapEx-$22.8M
Free cash flow$132.1M
Total assets$1.31B
Total liabilities$635.9M
Total equity$673.8M
Cash & equivalents$24.4M
Long-term debt$166.3M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$673.8M
Net cash-$141.9M
Current ratio1.2
Debt/Equity0.2
ROA9.9%
ROE19.2%
Cash conversion1.1%
CapEx/Revenue-8.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 4 companies
MetricVITROAActivity
Op margin12.2%8.0% medp25 -2.2% · p75 23.4%above median
Net margin46.0%5.5% medp25 -3.8% · p75 18.5%top quartile
Gross margin36.5%20.5% medp25 12.4% · p75 29.7%top quartile
R&D / revenue1.5% medp25 1.0% · p75 2.1%
CapEx / revenue-8.1%8.6% medp25 1.7% · p75 15.7%bottom quartile
Debt / equity25.0%37.1% medp25 10.3% · p75 82.0%below median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-14 00:44 UTC#8b7fe6d9
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 22:50 UTCJob: 45319d77